John F Crowley Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for John F Crowley.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of John F Crowley. John F Crowley is Chairman & CEO in AMICUS THERAPEUTICS INC ($FOLD) and Chairman, President & CEO in AMICUS THERAPEUTICS INC ($FOLD) and Executive Chairman in AMICUS THERAPEUTICS INC ($FOLD) and President & CEO in AMICUS THERAPEUTICS INC ($FOLD) and President and CEO in AMICUS THERAPEUTICS INC ($FOLD) and Director in Intellia Therapeutics, Inc. ($NTLA).
Latest Insider Trading Transactions of John F Crowley
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 25 2021 | NTLA | Intellia Therapeut ... | Crowley John F | Director | Option Exercise | A | 83.59 | 3,382 | 282,701 | 3,382 | |
| Jun 25 2021 | NTLA | Intellia Therapeut ... | Crowley John F | Director | Grant | A | 0.00 | 2,094 | 0 | 2,094 | 0 to 2.1 K |
| Jun 25 2021 | NTLA | Intellia Therapeut ... | Crowley John F | Director | Option Exercise | A | 83.59 | 3,382 | 282,701 | 3,382 | |
| Jun 25 2021 | NTLA | Intellia Therapeut ... | Crowley John F | Director | Grant | A | 0.00 | 2,094 | 0 | 2,094 | 0 to 2.1 K |
| Jun 09 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 4.38 | 1,443 | 6,320 | 134,935 | |
| Jun 09 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 6.45 | 20,557 | 132,593 | 0 | |
| Jun 09 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 10.01 | 29,500 | 295,192 | 877,230 | 906.7 K to 877.2 K (-3.25 %) |
| Jun 09 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 4.38 | 1,443 | 6,320 | 906,730 | 905.3 K to 906.7 K (+0.16 %) |
| Jun 09 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 6.45 | 20,557 | 132,593 | 905,287 | 884.7 K to 905.3 K (+2.32 %) |
| May 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 10.28 | 7,500 | 77,089 | 884,730 | 892.2 K to 884.7 K (-0.84 %) |
| Apr 26 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 10.01 | 7,683 | 76,898 | 892,230 | 899.9 K to 892.2 K (-0.85 %) |
| Apr 19 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 6.45 | 22,000 | 141,900 | 20,557 | |
| Apr 19 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 10.09 | 22,000 | 222,086 | 899,913 | 921.9 K to 899.9 K (-2.39 %) |
| Apr 19 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 6.45 | 22,000 | 141,900 | 921,913 | 899.9 K to 921.9 K (+2.44 %) |
| Apr 08 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Grant | A | 0.00 | 78,389 | 0 | 899,913 | 821.5 K to 899.9 K (+9.54 %) |
| Mar 24 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 10.29 | 7,682 | 79,061 | 829,024 | 836.7 K to 829 K (-0.92 %) |
| Mar 17 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 6.45 | 22,000 | 141,900 | 42,557 | |
| Mar 17 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 10.77 | 22,000 | 236,988 | 836,706 | 858.7 K to 836.7 K (-2.56 %) |
| Mar 17 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 6.45 | 22,000 | 141,900 | 858,706 | 836.7 K to 858.7 K (+2.63 %) |
| Feb 24 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 11.98 | 7,682 | 92,027 | 844,206 | 851.9 K to 844.2 K (-0.90 %) |
| Feb 18 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 6.45 | 22,000 | 141,900 | 64,557 | |
| Feb 18 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 12.26 | 22,000 | 269,700 | 851,888 | 873.9 K to 851.9 K (-2.52 %) |
| Feb 18 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 6.45 | 22,000 | 141,900 | 873,888 | 851.9 K to 873.9 K (+2.58 %) |
| Jan 20 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 6.45 | 22,000 | 141,900 | 86,557 | |
| Jan 20 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 21.51 | 50,000 | 1,075,325 | 859,388 | 909.4 K to 859.4 K (-5.50 %) |
| Jan 20 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 22.24 | 22,000 | 489,368 | 909,388 | 931.4 K to 909.4 K (-2.36 %) |
| Jan 20 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 6.45 | 22,000 | 141,900 | 931,388 | 909.4 K to 931.4 K (+2.42 %) |
| Jan 20 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Payment of Exercise | F | 21.84 | 31,608 | 690,161 | 909,388 | 941 K to 909.4 K (-3.36 %) |
| Jan 20 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Grant | A | 0.00 | 80,327 | 0 | 940,996 | 860.7 K to 941 K (+9.33 %) |
| Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | A | 21.78 | 185,585 | 4,042,041 | 185,585 | |
| Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Grant | A | 0.00 | 115,240 | 0 | 860,669 | 745.4 K to 860.7 K (+15.46 %) |
| Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 22.17 | 7,500 | 166,305 | 745,429 | 752.9 K to 745.4 K (-1.00 %) |
| Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Payment of Exercise | F | 23.09 | 19,994 | 461,661 | 752,929 | 772.9 K to 752.9 K (-2.59 %) |
| Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Payment of Exercise | F | 23.09 | 22,968 | 530,331 | 772,923 | 795.9 K to 772.9 K (-2.89 %) |
| Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Payment of Exercise | F | 23.09 | 11,335 | 261,725 | 795,891 | 807.2 K to 795.9 K (-1.40 %) |
| Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Payment of Exercise | F | 23.09 | 16,287 | 376,067 | 807,226 | 823.5 K to 807.2 K (-1.98 %) |
| Dec 16 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 6.45 | 22,000 | 141,900 | 108,557 | |
| Dec 16 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 23.91 | 22,000 | 526,101 | 823,513 | 845.5 K to 823.5 K (-2.60 %) |
| Dec 16 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 6.45 | 22,000 | 141,900 | 845,513 | 823.5 K to 845.5 K (+2.67 %) |
| Oct 05 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 5.96 | 20,000 | 119,200 | 23,975 | |
| Oct 05 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 14.02 | 29,900 | 419,105 | 840,913 | 870.8 K to 840.9 K (-3.43 %) |
| Oct 05 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 5.96 | 20,000 | 119,200 | 870,813 | 850.8 K to 870.8 K (+2.35 %) |
| Sep 02 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 5.96 | 20,000 | 119,200 | 43,975 | |
| Sep 02 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 14.18 | 29,900 | 423,850 | 850,813 | 880.7 K to 850.8 K (-3.39 %) |
| Sep 02 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 5.96 | 20,000 | 119,200 | 880,713 | 860.7 K to 880.7 K (+2.32 %) |
| Aug 19 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 5.13 | 20,000 | 102,600 | 62,485 | |
| Aug 19 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 14.89 | 20,000 | 297,814 | 860,713 | 880.7 K to 860.7 K (-2.27 %) |
| Aug 19 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 5.13 | 20,000 | 102,600 | 880,713 | 860.7 K to 880.7 K (+2.32 %) |
| Aug 19 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 5.13 | 20,000 | 102,600 | 62,485 | |
| Aug 19 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 14.89 | 20,000 | 297,814 | 860,713 | 880.7 K to 860.7 K (-2.27 %) |
| Aug 19 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 5.13 | 20,000 | 102,600 | 880,713 | 860.7 K to 880.7 K (+2.32 %) |
| Aug 05 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 5.96 | 20,000 | 119,200 | 63,975 | |
| Aug 05 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 14.78 | 39,655 | 586,081 | 860,713 | 900.4 K to 860.7 K (-4.40 %) |
| Aug 05 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 5.96 | 20,000 | 119,200 | 900,368 | 880.4 K to 900.4 K (+2.27 %) |
| Jul 17 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 5.13 | 20,000 | 102,600 | 82,485 | |
| Jul 17 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 15.54 | 20,000 | 310,848 | 880,368 | 900.4 K to 880.4 K (-2.22 %) |
| Jul 17 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 5.13 | 20,000 | 102,600 | 900,368 | 880.4 K to 900.4 K (+2.27 %) |
| Jul 06 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 5.96 | 20,000 | 119,200 | 83,975 | |
| Jul 06 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 15.48 | 39,655 | 613,859 | 880,368 | 920 K to 880.4 K (-4.31 %) |
| Jul 06 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 5.96 | 20,000 | 119,200 | 920,023 | 900 K to 920 K (+2.22 %) |
| Jun 17 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 5.13 | 20,000 | 102,600 | 102,485 | |
| Jun 17 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Payment of Exercise | F | 11.14 | 163 | 1,816 | 900,023 | 900.2 K to 900 K (-0.02 %) |
| Jun 17 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 10.88 | 20,000 | 217,610 | 900,186 | 920.2 K to 900.2 K (-2.17 %) |
| Jun 17 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 5.13 | 20,000 | 102,600 | 920,186 | 900.2 K to 920.2 K (+2.22 %) |
| Jun 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 12.66 | 9,755 | 123,452 | 900,186 | 909.9 K to 900.2 K (-1.07 %) |
| Jun 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Gift | G | 0.00 | 30,000 | 0 | 909,941 | 939.9 K to 909.9 K (-3.19 %) |
| May 19 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 5.13 | 20,000 | 102,600 | 122,485 | |
| May 19 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 11.44 | 20,000 | 228,796 | 939,941 | 959.9 K to 939.9 K (-2.08 %) |
| May 19 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 5.13 | 20,000 | 102,600 | 959,941 | 939.9 K to 959.9 K (+2.13 %) |
| May 05 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 11.32 | 9,755 | 110,469 | 939,941 | 949.7 K to 939.9 K (-1.03 %) |
| Apr 17 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 5.13 | 20,000 | 102,600 | 142,485 | |
| Apr 17 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 9.92 | 20,000 | 198,412 | 949,696 | 969.7 K to 949.7 K (-2.06 %) |
| Apr 17 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 5.13 | 20,000 | 102,600 | 969,696 | 949.7 K to 969.7 K (+2.11 %) |
| Apr 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Grant | A | 0.00 | 40,615 | 0 | 949,696 | 909.1 K to 949.7 K (+4.47 %) |
| Apr 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 9.08 | 9,755 | 88,608 | 909,081 | 918.8 K to 909.1 K (-1.06 %) |
| Mar 24 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 5.13 | 20,000 | 102,600 | 162,485 | |
| Mar 24 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 9.00 | 20,000 | 180,000 | 918,836 | 938.8 K to 918.8 K (-2.13 %) |
| Mar 24 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 5.13 | 20,000 | 102,600 | 938,836 | 918.8 K to 938.8 K (+2.18 %) |
| Mar 04 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 9.10 | 9,755 | 88,745 | 918,836 | 928.6 K to 918.8 K (-1.05 %) |
| Feb 20 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 5.13 | 20,000 | 102,600 | 182,485 | |
| Feb 20 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 10.83 | 20,000 | 216,676 | 928,591 | 948.6 K to 928.6 K (-2.11 %) |
| Feb 20 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 5.13 | 20,000 | 102,600 | 948,591 | 928.6 K to 948.6 K (+2.15 %) |
| Feb 04 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 8.91 | 9,754 | 86,882 | 928,591 | 938.3 K to 928.6 K (-1.04 %) |
| Feb 04 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Payment of Exercise | F | 8.84 | 19,994 | 176,747 | 938,345 | 958.3 K to 938.3 K (-2.09 %) |
| Jan 17 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 5.13 | 20,000 | 102,600 | 202,485 | |
| Jan 17 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 10.35 | 100,000 | 1,034,790 | 958,339 | 1.1 M to 958.3 K (-9.45 %) |
| Jan 17 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 5.13 | 20,000 | 102,600 | 1,058,339 | 1 M to 1.1 M (+1.93 %) |
| Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Payment of Exercise | F | 9.46 | 64,264 | 607,937 | 1,038,339 | 1.1 M to 1 M (-5.83 %) |
| Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Grant | A | 0.00 | 163,313 | 0 | 1,102,603 | 939.3 K to 1.1 M (+17.39 %) |
| Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Payment of Exercise | F | 9.46 | 64,264 | 607,937 | 1,038,339 | 1.1 M to 1 M (-5.83 %) |
| Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Grant | A | 0.00 | 163,313 | 0 | 1,102,603 | 939.3 K to 1.1 M (+17.39 %) |
| Jan 06 2020 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Payment of Exercise | F | 9.18 | 19,994 | 183,545 | 939,290 | 959.3 K to 939.3 K (-2.08 %) |
| Dec 18 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 5.13 | 20,000 | 102,600 | 222,485 | |
| Dec 18 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 9.55 | 20,000 | 191,014 | 735,694 | 755.7 K to 735.7 K (-2.65 %) |
| Dec 18 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 5.13 | 20,000 | 102,600 | 755,694 | 735.7 K to 755.7 K (+2.72 %) |
| Dec 04 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 3.82 | 20,000 | 76,400 | 31,439 | |
| Dec 04 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 10.38 | 20,000 | 207,618 | 735,694 | 755.7 K to 735.7 K (-2.65 %) |
| Dec 04 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 3.82 | 20,000 | 76,400 | 755,694 | 735.7 K to 755.7 K (+2.72 %) |
| Nov 27 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 3.82 | 40,000 | 152,800 | 51,439 | |
| Nov 27 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 10.01 | 40,000 | 400,204 | 735,694 | 775.7 K to 735.7 K (-5.16 %) |
| Nov 27 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 3.82 | 40,000 | 152,800 | 775,694 | 735.7 K to 775.7 K (+5.44 %) |
| Nov 19 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 5.13 | 20,000 | 102,600 | 242,485 | |
| Nov 19 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 9.52 | 20,000 | 190,390 | 735,694 | 755.7 K to 735.7 K (-2.65 %) |
| Nov 19 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 5.13 | 20,000 | 102,600 | 755,694 | 735.7 K to 755.7 K (+2.72 %) |
| Nov 19 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 5.13 | 20,000 | 102,600 | 242,485 | |
| Nov 19 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 9.52 | 20,000 | 190,390 | 735,694 | 755.7 K to 735.7 K (-2.65 %) |
| Nov 19 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 5.13 | 20,000 | 102,600 | 755,694 | 735.7 K to 755.7 K (+2.72 %) |
| Nov 12 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 5.13 | 20,000 | 102,600 | 262,485 | |
| Nov 12 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 9.02 | 20,000 | 180,414 | 735,694 | 755.7 K to 735.7 K (-2.65 %) |
| Nov 12 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 5.13 | 20,000 | 102,600 | 755,694 | 735.7 K to 755.7 K (+2.72 %) |
| Oct 15 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 8.01 | 14,500 | 116,073 | 735,694 | 750.2 K to 735.7 K (-1.93 %) |
| Sep 13 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 3.82 | 20,000 | 76,400 | 91,439 | |
| Sep 13 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 10.05 | 20,000 | 201,030 | 750,194 | 770.2 K to 750.2 K (-2.60 %) |
| Sep 13 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 3.82 | 20,000 | 76,400 | 770,194 | 750.2 K to 770.2 K (+2.67 %) |
| Aug 02 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 3.82 | 20,000 | 76,400 | 111,439 | |
| Aug 02 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 3.82 | 20,000 | 76,400 | 111,439 | |
| Aug 02 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 12.54 | 20,000 | 250,736 | 750,194 | 770.2 K to 750.2 K (-2.60 %) |
| Aug 02 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 12.54 | 20,000 | 250,736 | 750,194 | 770.2 K to 750.2 K (-2.60 %) |
| Aug 02 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 3.82 | 20,000 | 76,400 | 770,194 | 750.2 K to 770.2 K (+2.67 %) |
| Aug 02 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 3.82 | 20,000 | 76,400 | 770,194 | 750.2 K to 770.2 K (+2.67 %) |
| Jun 18 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Payment of Exercise | F | 11.35 | 205 | 2,327 | 750,194 | 750.4 K to 750.2 K (-0.03 %) |
| May 02 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 3.82 | 20,000 | 76,400 | 171,439 | |
| May 02 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 13.51 | 20,000 | 270,154 | 750,399 | 770.4 K to 750.4 K (-2.60 %) |
| May 02 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 3.82 | 20,000 | 76,400 | 770,399 | 750.4 K to 770.4 K (+2.67 %) |
| Apr 15 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Grant | A | 0.00 | 82,318 | 0 | 750,399 | 668.1 K to 750.4 K (+12.32 %) |
| Apr 03 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 3.82 | 9,791 | 37,402 | 191,439 | |
| Apr 03 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 3.19 | 10,209 | 32,567 | 0 | |
| Apr 03 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 13.63 | 20,000 | 272,626 | 668,081 | 688.1 K to 668.1 K (-2.91 %) |
| Apr 03 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 3.82 | 9,791 | 37,402 | 688,081 | 678.3 K to 688.1 K (+1.44 %) |
| Apr 03 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 3.19 | 10,209 | 32,567 | 678,290 | 668.1 K to 678.3 K (+1.53 %) |
| Mar 05 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 6.45 | 467 | 3,012 | 0 | |
| Mar 05 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 3.82 | 8,770 | 33,501 | 0 | |
| Mar 05 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 3.19 | 10,763 | 34,334 | 10,209 | |
| Mar 05 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 13.79 | 15,382 | 212,081 | 668,081 | 683.5 K to 668.1 K (-2.25 %) |
| Mar 05 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 12.97 | 4,618 | 59,898 | 683,463 | 688.1 K to 683.5 K (-0.67 %) |
| Mar 05 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 6.45 | 467 | 3,012 | 688,081 | 687.6 K to 688.1 K (+0.07 %) |
| Mar 05 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 3.82 | 8,770 | 33,501 | 687,614 | 678.8 K to 687.6 K (+1.29 %) |
| Mar 05 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 3.19 | 10,763 | 34,334 | 678,844 | 668.1 K to 678.8 K (+1.61 %) |
| Feb 05 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 3.82 | 20,000 | 76,400 | 210,000 | |
| Feb 05 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 12.12 | 20,000 | 242,320 | 668,081 | 688.1 K to 668.1 K (-2.91 %) |
| Feb 05 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 3.82 | 20,000 | 76,400 | 688,081 | 668.1 K to 688.1 K (+2.99 %) |
| Jan 17 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 10.36 | 103,500 | 1,072,260 | 0 | |
| Jan 17 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 11.71 | 103,500 | 1,212,296 | 668,081 | 771.6 K to 668.1 K (-13.41 %) |
| Jan 17 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 10.36 | 103,500 | 1,072,260 | 771,581 | 668.1 K to 771.6 K (+15.49 %) |
| Jan 10 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | A | 10.04 | 358,126 | 3,595,585 | 358,126 | |
| Jan 10 2019 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Grant | A | 0.00 | 233,477 | 0 | 668,081 | 434.6 K to 668.1 K (+53.72 %) |
| Jan 05 2018 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | A | 15.67 | 154,076 | 2,414,371 | 154,076 | |
| Jan 05 2018 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Grant | A | 0.00 | 106,603 | 0 | 434,604 | 328 K to 434.6 K (+32.50 %) |
| Jan 02 2018 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 3.53 | 5,920 | 20,898 | 1,538 | |
| Jan 02 2018 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 3.53 | 13,050 | 46,067 | 7,458 |